StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal Cord Injury Patient
22 sept. 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Sept. 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the first patient in the Company's breakthrough Phase I/II clinical trial in chronic spinal cord...
StemCells, Inc. Awarded CIRM Planning Grant to Pursue Preclinical Development of HuCNS-SC Cells for Alzheimer's Disease
01 sept. 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Sept. 1, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the California Institute of Regenerative Medicine (CIRM) has approved the Company's application for...
Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
26 août 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Aug. 26, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Roth Capital Partners initiated independent research coverage on the Company with a "Buy"...
StemCells, Inc. Reports Second Quarter Financial Results
28 juil. 2011 16h02 HE
|
StemCells, Inc.
NEWARK, Calif., July 28, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Second Quarter Financial Results and Business Update
25 juil. 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
New Publication Validates StemCells, Inc.'s SC Proven(R) Reagents for Automated Production and Cell-Based Screening
22 juil. 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD) announced today publication of a collaborative study which used commercially available SC Proven serum-free cell...
StemCells, Inc. Regains Compliance for Continued NASDAQ Global Market Listing
21 juil. 2011 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Relocates Corporate Headquarters and U.S. Research Labs
18 juil. 2011 16h12 HE
|
StemCells, Inc.
NEWARK, Calif., July 18, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has relocated its corporate headquarters and U.S.-based research and development operations to...
StemCells, Inc. Announces Reverse Stock Split
01 juil. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., July 1, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it will effect a one-for-ten reverse stock split at 12:01am on July 6, 2011. The Company...
StemCells, Inc. to Present Clinical Evidence of Long-Term Survival of HuCNS-SC(R) Cells Following Completion of Immunosuppression Regimen
15 juin 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., June 15, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it will present evidence of engraftment, migration and the long-term survival of its proprietary...